Jay Venkatesan, EVP and General Manager at Oncothyreon Inc. (ONTY), bought 250,000 shares at $2.00 ($500K) on 2014-09-23, disclosed to the SEC on 2014-09-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ANGN | BUY | 2022-05-25 | $101K | — | Filing → |
| ANGN | BUY | 2021-12-29 | $1.5M | — | Filing → |
| ANGN | BUY | 2021-12-22 | $9K | — | Filing → |